These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
706 related articles for article (PubMed ID: 26442970)
21. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma. Nguyen NP; Leonardo JM; Karlsson U; Vos P; Bullock L; Thomas P; Lepera P; Ludin A; Chu C; Salehpour M; Jendrasiak G; Sallah S Anticancer Res; 2002; 22(6B):3429-35. PubMed ID: 12552935 [TBL] [Abstract][Full Text] [Related]
22. A phase II study of concurrent nab-paclitaxel/carboplatin combined with thoracic radiotherapy in locally advanced squamous cell lung cancer. Wu K; Zhu L; Wang J; Pan K; Wang B; Li X; Yang S; Xu X; Zhang M; Li X; Chen X; Ma S; Xia B J Thorac Dis; 2019 Nov; 11(11):4529-4537. PubMed ID: 31903241 [TBL] [Abstract][Full Text] [Related]
23. The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial Pneumonias. Fujita T; Hiroishi T; Shikano K; Yanagisawa A; Hayama N; Amano H; Nakamura M; Hirano S; Tabeta H; Nakamura S Intern Med; 2018 Jul; 57(13):1827-1832. PubMed ID: 29434143 [TBL] [Abstract][Full Text] [Related]
24. A multi-institutional randomized phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin as regimens for concurrent chemoradiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1914. Shimoyama R; Omori S; Nomura S; Kenmotsu H; Takahashi T; Harada H; Ishikura S; Mizutani T; Ando M; Kataoka T; Fukuda H; Ohe Y; Jpn J Clin Oncol; 2021 Apr; 51(5):836-841. PubMed ID: 33728436 [TBL] [Abstract][Full Text] [Related]
25. A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC). Jain AK; Hughes RS; Sandler AB; Dowlati A; Schwartzberg LS; Dobbs T; Schlabach L; Wu J; Muldowney NJ; Choy H J Thorac Oncol; 2009 Jun; 4(6):722-7. PubMed ID: 19404213 [TBL] [Abstract][Full Text] [Related]
27. A phase II study of Endostatin in combination with paclitaxel, carboplatin, and radiotherapy in patients with unresectable locally advanced non-small cell lung cancer. Sun XJ; Deng QH; Yu XM; Ji YL; Zheng YD; Jiang H; Xu YP; Ma SL BMC Cancer; 2016 Apr; 16():266. PubMed ID: 27067521 [TBL] [Abstract][Full Text] [Related]
28. Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial. Socinski MA; Bondarenko I; Karaseva NA; Makhson AM; Vynnychenko I; Okamoto I; Hon JK; Hirsh V; Bhar P; Zhang H; Iglesias JL; Renschler MF J Clin Oncol; 2012 Jun; 30(17):2055-62. PubMed ID: 22547591 [TBL] [Abstract][Full Text] [Related]
29. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer]. Wang WH; Bao Y; Chen M; Zhang L; Li KX; Xu GC; Deng XW; Lu TX; Cui NJ Ai Zheng; 2006 Oct; 25(10):1279-83. PubMed ID: 17059776 [TBL] [Abstract][Full Text] [Related]
30. Phase I study of concurrent real-time tumor-tracking thoracic radiation therapy with paclitaxel and carboplatin in locally advanced non-small cell lung cancer. Sakakibara-Konishi J; Oizumi S; Kinoshita I; Shinagawa N; Kikuchi J; Kato M; Inoue T; Katoh N; Onimaru R; Shirato H; Dosaka-Akita H; Nishimura M Lung Cancer; 2011 Nov; 74(2):248-52. PubMed ID: 21397973 [TBL] [Abstract][Full Text] [Related]
31. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer. Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799 [TBL] [Abstract][Full Text] [Related]
32. Phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin in unresectable stage III non-small cell lung cancer. Zhang J; Gay HA; Russo S; Parent T; Aljumaily R; Walker PR Lung Cancer; 2014 Jan; 83(1):67-72. PubMed ID: 24246506 [TBL] [Abstract][Full Text] [Related]
33. Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer. Stinchcombe TE; Morris DE; Lee CB; Moore DT; Hayes DN; Halle JS; Rivera MP; Rosenman JG; Socinski MA J Thorac Oncol; 2008 Mar; 3(3):250-7. PubMed ID: 18317067 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic effect of induction therapy including nab-paclitaxel followed by surgical resection for the patients with locally advanced non-small-cell lung cancer. Uramoto H; Motono N; Iwai S J Cardiothorac Surg; 2024 Jul; 19(1):424. PubMed ID: 38970073 [TBL] [Abstract][Full Text] [Related]